Chun-Pyn Shen (沈君平) DDS PhD

Chun-Pyn Shen (沈君平) is a seasoned biopharmaceutical leader with over 30 years of experience in the medical product sector, particularly in biologics. He currently serves as the Vice President, Head of Regulatory Affairs, and Global Project Lead at IMPACT Therapeutics (英派药业). In this role, he is responsible for overseeing regulatory strategies and leading global projects within the company.

Education and Background

Dr. Shen holds a Doctor of Dental Surgery (DDS) and a PhD, which contribute to his expertise in regulatory affairs and project management within the biopharmaceutical industry. His educational background has equipped him with a solid foundation in both clinical practice and scientific research.

Professional Experience

Prior to his current position at IMPACT Therapeutics, Dr. Shen has held various leadership roles that have further honed his skills in regulatory compliance and project leadership. He was appointed as Head of Regulatory Affairs at IMPACT Therapeutics in September 2021, where he reports directly to the CEO and leads the department responsible for navigating the complexities of drug approval processes.

Contributions to the Field

Dr. Shen has been involved in significant clinical studies, including recent announcements related to Phase 3 clinical trials for treatments targeting advanced ovarian cancer. His work not only focuses on regulatory compliance but also on advancing innovative therapies that address unmet medical needs.

For more detailed insights into his professional journey, you can view his LinkedIn profile here .1